FTC Report Reveals PBM Oligopoly: Top 3 Control 80% of Market, Extract $7.3 Billion Through Markups

The Federal Trade Commission released its interim staff report titled ‘Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies,’ revealing alarming market concentration and anticompetitive practices. The report found that three PBMs—CVS …